--- title: "Ocugen Inc. Stock Rises Friday, Outperforms Market" type: "News" locale: "en" url: "https://longbridge.com/en/news/285778641.md" description: "Shares of Ocugen Inc. (OCGN) rose 4.86% to $1.51 on Friday, outperforming the market as the S&P 500 increased by 0.84% and the Dow Jones by 0.02%. This rise ended a three-day losing streak, although the stock remains 44.59% below its 52-week high of $2.73 reached on March 17. Trading volume was 10.1 million, surpassing the 50-day average of 9.7 million." datetime: "2026-05-08T21:30:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285778641.md) - [en](https://longbridge.com/en/news/285778641.md) - [zh-HK](https://longbridge.com/zh-HK/news/285778641.md) --- # Ocugen Inc. Stock Rises Friday, Outperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Ocugen Inc. (OCGN) rallied 4.86% to $1.51 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.84% to 7,398.93 and the Dow Jones Industrial Average rising 0.02% to 49,609.16. The stock's rise snapped a three-day losing streak. Ocugen Inc. closed 44.59% below its 52-week high of $2.73, which the company achieved on March 17th. Trading volume (10.1 M) eclipsed its 50-day average volume of 9.7 M. Data source: Dow Jones Market Data, FactSet. Data compiled May 8, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 05-08-26 1730ET ### Related Stocks - [OCGN.US](https://longbridge.com/en/quote/OCGN.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) ## Related News & Research - [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md) - [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md) - [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md) - [Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data](https://longbridge.com/en/news/286652611.md) - [MiNK Therapeutics' Q1 net loss narrows slightly](https://longbridge.com/en/news/286558132.md)